Form 4: Verastem Director Sells Shares to Cover Tax Obligations

Director Robert E. Gagnon sold 284 shares of Verastem, Inc. common stock on March 17, 2025, to satisfy tax withholding requirements related to vesting restricted stock units.

Summary

• On March 17, 2025, Robert E. Gagnon, a director of Verastem, Inc., sold 284 shares of common stock.
• The shares were sold at a price of $6.95 per share.
• The sale was executed to cover statutory withholding requirements associated with the vesting of restricted stock units.
• Following the transaction, Gagnon directly owns 34,193 shares of Verastem common stock.

Sentiment

Score: 5

Explanation: This is a neutral transaction related to tax obligations. It doesn't indicate positive or negative sentiment towards the company's future prospects.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company directors and officers. This transaction is a routine part of equity compensation and doesn't necessarily indicate a change in the director's confidence in the company.

Comparison to Industry Standards

• It's difficult to compare this transaction directly to industry standards without knowing the specifics of Verastem's equity compensation plan and the director's overall holdings.
• However, similar transactions are regularly disclosed by executives and directors across various industries as part of their equity compensation packages.
• Companies like Amgen, Gilead, and Biogen often see similar filings from their executives.

Stakeholder Impact

• The sale is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors.

Key Dates

Keywords

Verastem, Director, Gagnon, Share Sale, Form 4, VSTM, Restricted Stock Units, Tax Withholding